RESUMO
Context Although the Modified Harris Hip Score (MHHS) is used worldwide, it has not been translated into Arabic or validated for use among Arabic populations. Aim This study aimed to translate the MHHS into Arabic and to culturally adapt and validate the Arabic version. Design A cross-sectional study of the MHHS was performed. Methods The MHHS was translated into Arabic using forward-backward translation. A total of 183 adults who could speak and read Arabic completed the questionnaire. Cronbach's alpha was used to assess internal consistency with respect to the total and subscale scores. Pearson's correlation coefficient was used to evaluate associations between the total scores, and the subscales and intersubscales. Test-retest reliability was assessed using the intraclass correlation coefficient (ICC). The Kaiser-Meyer-Olkin value was determined before principal component analysis to evaluate the validity of the construct and the reliability of the data, and correlations among the score items were estimated. Results All the participants understood the questions. The ICCs for the total score, function subscale, and pain subscale were 0.936, 0.936 and 0.893, respectively. Cronbach's alpha was acceptable for the total score (0.792) and good for the function subscale (0.895). The total score and the function (r = 0.976; p < 0.001) and pain (r = 0.971; p < 0.001) subscales correlated significantly. Regarding score validity, all the MHHS items correlated with the total score (p < 0.001). Conclusions The reliability and validity of the Arabic version of the MHHS was demonstrated. The MHHS can be used to assess hip pathology among adults in Saudi Arabia.
RESUMO
INTRODUCTION: Developmental dysplasia of the hip (DDH) is a common hip disorder and its association with other musculoskeletal, genetic, and neurological diseases were well described in the literature. Juvenile idiopathic arthritis (JIA) is a rare rheumatological condition, and its presence in a Developmental dysplasia of the hip (DDH) child makes this a very challenging case. PRESENTATION OF THE CASE: This case report is describing the presentation of 9 months old girl to orthopedic service referred from the pediatric rheumatology clinic after diagnosing her and starting the treatment for Juvenile idiopathic arthritis (JIA). Bilateral neglected Developmental dysplasia of the hip (DDH) - International Hip Dysplasia Institute (IHDI) type 4- was detected during her clinical and radiological assessment, necessitating surgical management after controlling her Juvenile idiopathic arthritis (JIA). The surgical procedure and its clinical and radiological outcomes more than four years after her surgical treatment are described in detail in this report as well. DISCUSSION: The management of Developmental dysplasia of the hip (DDH) associated with Juvenile idiopathic arthritis (JIA) has no established guidelines in literature. Here, we share our experience in managing such rare cases. We believe that medical control of Juvenile idiopathic arthritis (JIA) before proceeding for open reduction of Developmental dysplasia of the hip (DDH) is the key to successful results. CONCLUSION: The reported case is uniquely having both Developmental dysplasia of the hip (DDH) and Juvenile idiopathic arthritis (JIA) treated with open reduction, pelvic osteotomy, and femoral shortening resulting in outstanding clinical and radiological outcomes.
RESUMO
BACKGROUND: The prevalence of gastroparesis in type 2 diabetes mellitus (T2DM) vary widely. Our aim is to estimate the prevalence of clinical symptoms of gastroparesis among patients with type 2 diabetes mellitus and explore the relationship between gastroparesis and other risk factors. METHODS: A cross-sectional study evaluating 147 type 2 diabetics using the Gastroparesis Cardinal Symptoms Index (GCSI). A GCSI Total Score ≥ 1.90 were chosen as having definite symptoms of gastroparesis. All patients completed a demographic questionnaire and interviewed to complete the. Demographic Data, disease duration, Medication, comorbidities, recent blood glucose and HbA1C were collected and investigated. RESULTS: The prevalence of clinical symptoms of gastroparesis among type 2 diabetics was 10.8%. Clinical symptoms of gastroparesis were significantly correlated to HbA1c (p=0.001), blood glucose (p= 0.003), duration of diabetes (p= 0.02) and comorbidities (p=0.009). The most common symptoms were bloating, stomach fullness and early satiety (63.94%, 55.1% and 48.3% respectively). In logistic regression analysis, female gender emerged as significant independent predictors of the presence of at least one symptom. CONCLUSIONS: The prevalence of clinical symptoms of gastroparesis observed in the Saudi patientsdiagnosedwithtype2 diabetes was 10.8% and is independently associated with poor controlled diabetes, hyperglycemia, and long duration of diabetes and history of Co-morbid conditions.
